Stanford University at PMWC 2027

Jan 27–29, 2027 Santa Clara, CA ~3k attendees Website

Stanford University takes part in 23 sessions at PMWC 2027 in Santa Clara, and exhibits at Booth A402. Its program spans every PMWC track, with the heaviest presence in liquid biopsy, where it chairs a day on therapy guidance and monitoring. Its sessions also cover cell therapy, spatial proteomics, computational pathology and neurodegeneration.

OrganizationPMWC 2027 Attendance
Universities & research institutesExhibitor
Private research university; most of its speakers here are from Stanford Medicine, whose genomics and personalized medicine center exhibits.
Booth
Exhibiting at Booth A402
PMWC Luminary Award honoree
3 PMWC Pioneer Award honorees
Panel
Wed Jan 27
9:20am
Part of Track 2: Multimodal AI in Diagnostics
Fireside Chat
with Microsoft
Panel
Wed Jan 27
9:45am
Part of Track 1: Engineered Cell and Gene Therapy Platforms
Off-the-Shelf Cell Therapies: NK, iPSC, and Allogeneic T Cells, What Wins?
with Allogene Therapeutics, Nkarta, MD Anderson Cancer Center
Panel
Wed Jan 27
9:45am
Part of Track 2: Multimodal AI in Diagnostics
Beyond the Glass Slide: What Computational Pathology Sees That Humans Cannot
with Emory University, University of Pittsburgh, PathAI
Panel
Wed Jan 27
11:00am
Part of Track 5: Spatial Biology and Tissue Architecture
Spatial Proteomics: From Cell States to Therapeutic Targets
with Genentech
Panel
Wed Jan 27
1:00pm
Part of Track 3: From Screening to Interception: Diagnostics Enter the Clinic
Treating Disease at the Earliest Stage
with Harvard University, Dana-Farber Cancer Institute
Panel
Wed Jan 27
2:00pm
Part of Track 1: Engineered Cell and Gene Therapy Platforms
Why Cell Therapies Fail in Solid Tumors and What Actually Works
with Rutgers Cancer Institute, USC, Weill Cornell Medicine +1 more
Panel
Wed Jan 27
2:30pm
Part of Track 5: Spatial Biology and Tissue Architecture
AI for Spatial Biology: Foundation Models and Digital Pathology
with MIT
Panel
Wed Jan 27
4:15pm
Part of Track 3: From Screening to Interception: Diagnostics Enter the Clinic
SESSION 5B - AI Across Multimodal Signals
with Harvard University, Dana-Farber Cancer Institute, UCSF +1 more
Track
Thu Jan 28
All day
Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
Track chair
Talk
Thu Jan 28
11:00am
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
Cell-free RNA for treatment response and resistance.
Panel
Thu Jan 28
11:15am
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
Advanced Cancer and Recurrence: Monitoring Response, Detecting Resistance, and Knowing When to Switch
with Johns Hopkins University, AstraZeneca, Quest Diagnostics +2 more
Panel
Thu Jan 28
1:00pm
Part of Track 4: Integration & Implementation of Precision Medicine
CDS That Clinicians Will Use
with University of Pennsylvania, UCSF, VA Palo Alto Health Care System +2 more
Panel
Thu Jan 28
1:00pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Turning Biomarkers on Their Head: What We Can Measure Before We Can Predict
with UCSF, Genentech, Yale University +1 more
Panel
Thu Jan 28
2:15pm
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
When Tissue, Liquid, and Imaging Disagree: Which Result Should Guide Treatment?
with Adaptive Biotechnologies, Mount Sinai, Agilent
Panel
Thu Jan 28
3:30pm
Part of Track 2: Clinical AI: Deployment, Decision Support and RWE
AI Safety, Governance, and Evaluation
with Coalition for Health AI, UC Berkeley, UCSF +2 more
Panel
Thu Jan 28
3:30pm
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
MRD as a Surrogate Endpoint for Accelerated Drug Approval: Successes and Challenges
with University of Miami, Virginia Tech, Amgen +4 more
Panel
Thu Jan 28
3:30pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
The Microbial Roots of Autoimmunity: Chronic Infection and Dysbiosis
with NYU Langone Health, Gilead Sciences
Panel
Fri Jan 29
9:15am
Part of Track 3: Blood-Based Diagnostics Beyond Cancer
Transplant & Organ Health Diagnostics: From Biopsy to Noninvasive Monitoring
with Cornell University, KU Leuven, AP-HP +1 more
Panel
Fri Jan 29
9:30am
Part of Track 1: Programmable Genetic Medicines
Programming Protein Fate: Molecular Glues, Degraders, and Induced Proximity
with Amgen, Nurix Therapeutics
Panel
Fri Jan 29
11:00am
Part of Track 3: Blood-Based Diagnostics Beyond Cancer
Diagnosing the Undiagnosed: Blood-Based Omics and Host Response in Infection
with UCSF, CDC, Karius
Panel
Fri Jan 29
1:00pm
Part of Track 5: Precision Neurology & Neurodegenerative Disease
Neurodegeneration Beyond AD: Parkinson’s, ALS, FTD
with MIT, University of Pennsylvania, Mass General Brigham +1 more
Panel
Fri Jan 29
2:00pm
Part of Track 1: Programmable Genetic Medicines
In Vivo Delivery and Vector Engineering
with UC Berkeley, Lyora Therapeutics, Scribe Therapeutics
Panel
Fri Jan 29
2:15pm
Part of Track 4: Precision Aging, Prevention & Healthspan
Wearables & Digital Biomarkers at Scale
with Google, Amsterdam UMC, Apple
Also
Presenting at the meeting, beyond the sessions above

Explore the full PMWC 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Santa Clara. Leave your work email and we’ll be in touch.

Privacy

Download the full PMWC 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Stanford University

Tell us what you sell and we’ll find the people at Stanford University most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by PMWC or its organizers. Submit a correction